Dr. Steven E. Finkelstein M.D., DABR, FACRO, received his M.D. from the University of Michigan in 1997 graduating cum laude eruditions causa. He joined the National Cancer Institute (NCI), National Institutes of Health (NIH) as Clinical Associate in 1999 and completed both Surgical Oncology Fellowship as well as Clinical Immunotherapy Fellowship in 2004. Dr. Finkelstein has been recognized as a Castle Connolly Top Doctor for five years in a row.
Dr. Steven E. Finkelstein M.D., DABR, FACRO, received his M.D. from the University of Michigan in 1997 graduating cum laude eruditions causa. He joined the National Cancer Institute (NCI), National Institutes of Health (NIH) as Clinical Associate in 1999 and completed both Surgical Oncology Fellowship as well as Clinical Immunotherapy Fellowship in 2004. Dr. Finkelstein has been recognized as a Castle Connolly Top Doctor for five years in a row.
The reviews listed below were collected independently of Associated Medical Professionals through rater8. Each review represents an authentic and verified patient experience.
Explained everything so that I understood each step and why he chose to proceed in this manner. Excellent bedside manner.
(2 weeks ago)
Jul-2026
Waited 45 min after treatment at that point I was late for work. Left with out seeing him
(2 weeks ago)
Jul-2026
Very professional in all aspects of this visit. Blessed to have found AMP for my needs. Highly recommend!!!
(2 weeks ago)
Jul-2026
Very good. Thorough. Well verdef in his craft and supported by a quality skilled staff.
(8 months ago)
Nov-2025
Coercive
(9 months ago)
Nov-2025
Very knowledgeable, professional and to the point.
(10 months ago)
Oct-2025
Excellent care
(10 months ago)
Oct-2025
He was remarkable, no beating around the bush. A straight shooter, so knowledgeable and made me realize how serious my cancers are. Getting a second opinion with Dr. Finkelstein was the best decision I could have made. I am grateful to him and can’t thank him enough.
(10 months ago)
Sep-2025
Dr Finkelstein was very good at explaining everything. He was very compassionate and answered all questions. He took time to make sure that we understood everything. We were never felt rushed .
(10 months ago)
Sep-2025
Five star of course
(10 months ago)
Sep-2025
Read More
Rad Onc: Syracuse
1226 East Water Street Syracuse, NY 13210
AMP: Syracuse, NY
1226 East Water Street Syracuse, NY 13210
Dr. Steven E. Finkelstein M.D., DABR, FACRO, received his M.D. from the University of Michigan in 1997 graduating cum laude eruditions causa. He joined the National Cancer Institute (NCI), National Institutes of Health (NIH) as Clinical Associate in 1999 and completed both Surgical Oncology Fellowship as well as Clinical Immunotherapy Fellowship in 2004. Following completion of an additional radiation oncology residency, Dr. Finkelstein was selected as Chief Resident in Radiation Oncology at Moffitt Cancer Center/University of South Florida. In 2011, he was recruited to join the 21C Translational Research Consortium (TRC) and was appointed its National Director. In 2014, he was promoted to 21C Chief Science Officer. In 2017, he returned to Florida to serve as Cancer Director of Bay Regional Cancer Center at AUI. In 2019, Dr. Finkelstein joined the US Oncology Network at Florida Cancer Affiliates to continue advancing patient access to novel, advanced cancer care.
Dr. Finkelstein has a special interest in the study and patient care and research of a variety of cancers, using radiation driven, and personalized systemic therapy. Accordingly, he holds three International patents in the field of cutting edge technologies.
Dr. Finkelstein has given national and international lectures, published numerous professional journal articles and written book chapters, resulting in over 11,000 literature citations with an H-Index of 42. Additionally, he is renowned in bladder, kidney and testicular cancer as well as lung, breast and skin cancers which he also treats at A.M.P. He also serves on the editorial board of key international journals, including the American Society of Clinical Oncology (ASCO) as the ASCO Associate Editor for Immunotherapy.
For these contributions to patients, Dr. Finkelstein was one of the youngest physicians to receive accelerated fellowship in the American College of Radiation Oncology (ACRO) in 2017 and elected to the ACRO Board of Chancellors and Chair of Education in 2018.
Dr. Finkelstein has been recognized as a Castle Connolly Top Doctor for five years in a row.
See other doctors in Associated Medical Professionals
Explained everything so that I understood each step and why he chose to proceed in this manner. Excellent bedside manner.
Waited 45 min after treatment at that point I was late for work. Left with out seeing him
Very professional in all aspects of this visit. Blessed to have found AMP for my needs. Highly recommend!!!
Very good. Thorough. Well verdef in his craft and supported by a quality skilled staff.
Coercive
Very knowledgeable, professional and to the point.
Excellent care
He was remarkable, no beating around the bush. A straight shooter, so knowledgeable and made me realize how serious my cancers are. Getting a second opinion with Dr. Finkelstein was the best decision I could have made. I am grateful to him and can’t thank him enough.
Dr Finkelstein was very good at explaining everything. He was very compassionate and answered all questions. He took time to make sure that we understood everything. We were never felt rushed .
Five star of course